Slide 1: Presentation on Financial Results cover letter
May 6, 2023 Ref. No.: AIL/SE/13/2023-24 To, BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Dalal Street, Fort, Bandra Kurla Complex, Bandra (E), Mumbai-400001, MH. Mumbai-400051, MH. Scrip Code: 543534 Symbol: AETHER Dear Madam / Sir, Subject: Present
Slide 2: Q4 2023 Investor Presentation
Q4 2023 06 May, 2023 AETHER.NS 543534
Slide 3: Why Aether?
WHY AETHER? The True Story R&D Driven Approach Growth Engines 1st Time In India [8 x 8] Matrix of chemistry/ Deep-rooted R&D-led Successfully launched 3 Most of our advanced technology competencies product development team business models in 5 years intermediates and developed in-house, from compris
Slide 4: Highlights
HIGHLIGHTS New Countries Team Members We have started business in 4 new countries in FY23, which More than 80 new team members joined Aether in Q4 FY23 earmarks the growth of Aether geographically across all departments New Customers Customer Audits We have started business with 13 new customers dur
Slide 5: Site 3 production of products commenced
SITE 3 Production of 3 Products Commenced Located diagonally opposite to the current Manufacturing Facility 2 in GIDC, Sachin, Surat, Gujarat, India Additional 3500 MT capacities approximately per annum added January 2023 facility operational
Slide 6: Otsuka | Aramco
OTSUKA | ARAMCO Aether Industries Limited, executed a long-term Aether Industries Limited has executed a letter of for initially 10 years’ supply and sales agreement intent with Saudi Aramco Technologies Company, with Otsuka Chemicals Co., Ltd., Japan, along Saudi Arabia. with Chori Co., Ltd., Japan
Slide 7: Addition in Leadership Team
ADDITION IN LEADERSHIP TEAM • PhD Organic Chemistry – University of Rochester • >20 years Eastman Kodak – Worldwide Director of Process Development & Manufacturing • 7 years Senior VP Novomer, Inc.; CO2 Polyol Technology acquired by Saudi Aramco 2016 • 7 years with Saudi Aramco; President & CEO Aram
Slide 8: Site 5 Inauguration - Blood Donation Camp
SITE 5 INAUGURATION - BLOOD DONATION CAMP 706 Inauguration of Manufacturing Site 5 (Panoli GIDC, Bharuch, Gujarat) was done by brick laying rituals and conducting a blood donation camp, where in various corporates in Panoli, Panoli Industries Association, Kumarpal Blood Bank and Rotary Club Bottles
Slide 9: Snapshot
SNAPSHOT Q-o-Q Q-o-Q is comparison of Q4 FY23 with Q3 FY23 (INR MM) Revenue EBITDA PAT 1,844 602 376 Q4FY23 10% 19% 7% Q3FY23 1,705 507 350 Y-o-Y Y-o-Y is comparison of Q4 FY23 with Q4 FY22 1,844 602 376 Q4FY23 25% 42% 44% 1,477 423 260 Q4FY22
Slide 10: Snapshot
SNAPSHOT FY-o-FY FY-o-FY is comparison of FY23 with FY22 (INR MM) Revenue EBITDA PAT 6,676 2,028 1,304 Q4FY23 12% 16% 20% Q3FY23 5,970 1,751 1,089
Slide 11: Business Segments
BUSINESS SEGMENTS (INR MM) Large Scale FY18 885 52% FY19 1,473 Manufacturing FY20 2,489 FY21 3,249 Advanced intermediates and speciality chemicals FY22 3,955 with application across the industry spectrum FY23 3,357 Contract Research and Manufacturing FY18 63 13% FY19 202 Services - CRAMS FY20 275 FY
Slide 12: Aether Today
AETHER TODAY GROSS REVENUE (INR MM) 34.7% Agro CAGR 44% 6,511 5,970 4,538 By Application 8.7% Multiple 3,038 Pharma 2,033 5.7% Photography 42.2% 4.9% Material Science 1,092 3.4% Coatings 0.4% Others FY18 FY19 FY20 FY21 FY22 FY23 EBITDA% 29.3% 30.4% FY23 24.4% 24.3% 25.3% 21.7% FY18 FY19 FY20 FY21 FY
Slide 13: Research and Development
RESEARCH AND DEVELOPMENT R&D has been critical to success and a differentiating factor vis-à-vis competitors Experts at helm of R&D / CRAMS Consistently rising R&D expenditure MARCH-22 MARCH-23 7.5% 164 233 6.6% Highly quali ed employees, Highly quali ed employees, including including 4.3% 4.0% (INR
Slide 14: IPO Fund Utilisation
IPO FUND UTILISATION 1. Capital expenditure was done towards the Manufacturing Site 3, which has been operational from January 2023. 2. Working Capital cycle of the company being monitored well for reducing it upto desired levels 3. Aether is a debt free company as all the term loans are fully paid
Slide 15: Financial Results for Q4 FY23 and FY23
Financial Results for Q4 FY23 and FY23 (INR MM) Particulars Q4FY23 Q3FY23 Q4FY22 FY23 FY22 Audited Unaudited Audited Audited Audited Revenue from operations 1,838 1,671 1,475 6,511 5,900 Other income 6 34 2 165 70 Total income 1,844 1,705 1,477 6,676 5,970 Cost of goods sold # 871 790 731 3,173 2,88
Slide 16: Balance Sheet
Balance Sheet INR MM FY20 FY21 FY22 FY23 INR MM FY20 FY21 FY22 FY23 ASSETS EQUITY AND LIABILITIES Non-Current Assets Equity Property, plant and equipment 1,206 2,065 2,355 5,333 Equity share capital 86 101 1,127 1,245 Capital work-in-progress 172 2 577 372 Other equity 697 1,642 2,742 11,201 Investm
Slide 17: Cash Flow Statement
Cash Flow Statement INR MM FY20 FY21 FY22 FY23 Cash generated from operations 309 432 284 253 Net cash from operating activities 177 232 (54) (66) Net cash (used in) investing activities (480) (766) (1,509) (3,484) Cash ow from nancing activities Net cash used in nancing activities 326 554 1,688 4,3
Slide 18: Core Competencies
CORE COMPETENCIES Chemistry Technology Grignards and Organolithiations Continuous Reaction Ethylene Oxide Chemistry Batch Reaction - Tandem Grignard / Ethylene Oxide High Pressure Reaction Isobutylene Chemistry Fixed Bed Reaction Chemistry Technology Hydrogenation Cryogenic Reaction Matrix 8x8 - Asy
Slide 19: Product Selection
Sweet Spot PRODUCT SELECTION Core competencies of chemistry, technology and systems No active manufacturer in India, made for 1st time in India Minimum 4 step sequences of manufacturing and infrastructure oriented Generate adequate revenue at maturity Market leading position at product maturity Prod
Slide 20: Key Pillars
KEY PILLARS • Bachelor of Chemical Engineering • Bachelor of Chemical Technology - ICT from Institute of Chemical (UDCT, 2005), PhD in Organic Chemistry Technology (UDCT, 1974) from Michigan State University (USA, • Distinguished Alumni Award by 2010) UDCT (2010) • Prior to Aether, project leader in
Slide 21: Experienced Board
EXPERIENCED BOARD Kamalvijay Tulsian Jeevan Lal Nagori Leja Hattiangadi Dr. Amol Kulkarni Chairman, Non-Executive Non-Executive Independent Non-Executive Independent Non-Executive Director Director Director Independent Director Decades of experience in Experience 34 years in Decades of experience in
Slide 22: Business Development Leaders | SMP and KMP
BUSINESS DEVELOPMENT LEADERS | SMP AND KMP • Bachelor’s Science (Purdue • Diploma Physics and Doctorate Univ. USA) and PhD Organic of Natural Sciences (PhD), Chemistry (Univ. Wisconsin, Univ. Hannover (Germany) USA) • Decades of experience in • > 30 years at The Dow Chemical Industry Chemical Compan
Slide 23: Select Marquee Customer Base | Domestic and Global
SELECT MARQUEE CUSTOMER BASE | DOMESTIC AND GLOBAL Pharmaceutical Oil and Gas Textiles High performance photography Material Science | Coatings Agrochemical Other Sectors TOSOH FineChem
Slide 24: QEHS
QEHS Health and Safety ISO 9001 TFS • Undertaking hazard and operability studies before For Quality Audited Sites for Together for Sustainability commencing commercial production of new products • Dedicated team of safety personnel • Mobile application for safety and emergencies ISO 45001 INDIAN GMP
Slide 25: QEHS
QEHS Quality Environment High standards of quality for products Vibrant infrastructure installed for environment and sustainability efforts To cover To ensure • 100 KLPD in-house zero liquid discharge (ZLD) plant • Triple stage multiple effect evaporator (MEE) • Mechanical vapour recompression (MVR)
Slide 26: Environmental Social Governance
ENVIRONMENTAL SOCIAL GOVERNANCE Environmental Social Governance • Adoption of the green chemistries or • Focused on: • Technically sound and extensively more accurately sustainable chemistry - Education ( especially for girls ) experienced Board members since inception. - Skill development • Transpa
Slide 27: Forward-looking statements disclaimer
Certain statements and opinions with respect to the anticipated future performance of the company in the presentation (“forward - looking statements”), which reflect various assumptions concerning the strategies, objectives and anticipated results may or may not prove to be correct. Such forward -lo